Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 2 of the last 4 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 27 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
AXINESIS from Wavre, company number BE0628807052, closed financial year 2025 with a result of € -522,816 after tax. For that financial year AXINESIS recorded a gross margin of € 636,355 and equity of € -1.2 million. Compared with financial year 2024, the result moved from € -1.2 million to € -522,816. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on February 11, 2026.
€ -1.2 million
▼ € 522,790 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -522,816
▲ 57 % less loss than in 2024
Profit after tax over the fiscal year.
€ 899
▲ 13% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -4.5 million.
People and assets in 2025
7.9
▼ 3.6 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 683,270
▼ 40% vs 2024
€ 86,500 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 11,102
▼ 54% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 2.2 million
▲ 18% vs 2024
€ 124,231 is repaid this year. At this pace the long-term loan is gone in ≈ 17 years.
€ 305,049
▲ 57% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 75,003
▼ 31% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -82,729 | € 217,514 | € 493,748 | € 636,355 | ▲ 29% |
| Profit after taxes | € -629,694 | € -745,809 | € -1,220,884 | € -522,816 | ▲ € 698,068 |
| Equity | € 1,106,450 | € 406,520 | € -630,311 | € -1,153,101 | ▼ € 522,790 |
| Total debts | € 474,200 | € 1,044,346 | € 2,357,898 | € 2,823,040 | ▲ 20% |
| Cash | € 508,928 | € 671 | € 795 | € 899 | ▲ 13% |
| Retained profit | € -1,961,151 | € -2,706,959 | € -3,927,843 | € -4,450,659 | ▼ € 522,816 |
| Bank debt | € 179,109 | € 627,896 | € 1,897,149 | € 2,241,457 | ▲ 18% |
| Balance sheet total | € 1,580,649 | € 1,450,867 | € 1,727,587 | € 1,669,939 | ▼ 3% |
| Employees (FTE) | - | - | 11.5 | 7.9 | ▼ 3.6 |
Key figures of AXINESIS, fiscal years 2021 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
What happened to AXINESIS?
What happened at AXINESIS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- HUBTECH SRL stepped down as director. NBB
- VIVES PARTNERS stepped down as director. NBB
- INVEST BW SA stepped down as director. NBB
- RITME SRL stepped down as director. NBB
- SPARAXIS SA stepped down as director. NBB
- MERCATOR MEDICAL CONSULT SRL stepped down as director. NBB
- INNOVATION FUND SA stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 522,816. filed late Source: NBB ↗
In short
From € 629,694 loss in 2021 to € 522,816 loss in 2025.
Paid € 182 in corporate taxes since 2021.
On average € 80,600 of value added per employee in 2025.
A new publication or filing at AXINESIS? We notify you, reason included.
Follow AXINESISDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of SOCIETE D'INVESTISSEMENT ET DE FINANCEMENT DU BRABANT WALLON, VIVES II - Louvain Technology Fund, INNOVATION FUND, SOPARTEC comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
AXINESISThe shares are held by SOCIETE D'INVESTISSEMENT ET DE FINANCEMENT DU BRABANT WALLON (25.5%), VIVES II - Louvain Technology Fund (25.4%), INNOVATION FUND (12.7%) and SOPARTEC (5.9%).
Directors
According to the 2025 annual accounts
Director · represented by JULIEN SAPIN
since 2022 · until 2028
Director · represented by ANDRE VANDEMEULEBROEKCE
Also active at: NOVADIP BIOSCIENCES, TESSARES, Sunrise, ViroVet, The Akkermansia Company, VOCSens, Vives Inter-University Fund, NeGIO Therapeutics +4 more
since 2022 · until 2028
Director · represented by SOPHIE SAUVAGE
Also active at: C.P. Bourg, A.M.B., Jean Goldschmidt International, Ateliers Pierre Cerfontaine, Floridienne, Fonderies J. Marichal Ketin et Cie, JUNGLING, MEBF +223 more
since 2020 · until 2026
Managing director · represented by PIETER VAN DEN STEEN
since 2020 · until 2026
Director · represented by PIERRE de WAHA
Also active at: SOCIETE D'ASSAINISSEMENT ET DE RENOVATION DES SITES INDUSTRIELS DU BRABANT WALLON, SYBERMAT, SCALE UP, TCO Service, Made in BW, Whitestone Group, n-Side, CROSSFACTORY +23 more
since 2022 · until 2028
Director · represented by EDITH COUNE
Also active at: HOME EOS, FYTEKO, IRISTICK, InOpSys, ALLERINVEST, Zeopore Technologies, APAXEN, LIVEDROP +2 more
since 2020 · until 2026
since 2022 · until 2028
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Avenue Sabin 3
1300 Wavre
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
one.com Mail
Hosting
CLOUDFLARENET - Cloudflare, Inc., US
DNS
Cloudflare DNS
Domain
Domain
axinesis.com
Registered
2010-10-11
Registrar
Hosting Concepts B.V. d/b/a Registrar.eu
Expires
2026-10-11
Website info
Features
Security
Network
Details
- Company number
- 0628.807.052
- VAT number
- BE 0628.807.052
- Registered office
- Avenue Sabin 3, 1300 Wavre
- Names & denominations
- AXINESIS
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 22 April 2015
- Peppol
- Active · Active since 24 Nov 2025
- Contact
- axinesis.com
- Activities · NACE
Vervaardiging van bestralingsapparatuur en van elektromedische en elektrotherapeutische apparatuur
Ontwerpen van computerprogramma’s
Uitgeven van overige software
Activiteiten van ingenieurs en aanverwante technische adviseurs, exclusief landmeters-experts
Ontwerpen en programmeren van computerprogramma's